![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/48 | |
A61P 7/04 | |||
A61K 35/14 |
(11) | Number of the document | 2364165 |
(13) | Kind of document | T |
(96) | European patent application number | 09756209.4 |
Date of filing the European patent application | 2009-11-11 | |
(97) | Date of publication of the European application | 2011-09-14 |
(45) | Date of publication and mention of the grant of the patent | 2018-01-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2009/064060 |
Date | 2009-11-11 |
(87) | Number | WO 2010/056765 |
Date | 2010-05-20 |
(30) | Number | Date | Country code |
114948 P | 2008-11-14 | US |
(72) |
LU, Genmin, US
SINHA, Uma, US
|
(73) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
(54) | ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTS |
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTS |